Quinlan Paul T

CIK 00013332773 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001333277

Recent Transactions

50 trades

Award
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-01-23+32,500→ 32,500 total
Award
Oruka Therapeutics, Inc.$ORKA
Employee Stock Option (right to buy)
2026-01-23+130,000→ 130,000 total
Award
Oruka Therapeutics, Inc.$ORKA
Employee Stock Option (right to buy)
2025-01-22+162,500→ 162,500 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Common Stock
2024-03-22−28,438→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−233,176→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−107,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−105,625→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−215,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−22,167→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Common Stock
2024-03-22−41,824→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-13−41,824→ 8,872 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-03-13$7.89/sh+41,824→ 70,262 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-24+105,625→ 105,625 total
Award
CymaBay Therapeutics, Inc.
Common Stock
2024-01-24+28,438→ 28,438 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2024-01-16$23.58/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-16−5,000→ 107,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-01-16$2.94/sh+5,000→ 5,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-12-15$2.94/sh+5,000→ 5,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-12-15−5,000→ 112,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-12-15$21.98/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-11-15−5,000→ 117,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-11-15$2.94/sh+5,000→ 5,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-11-15$17.38/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-10-16−5,000→ 122,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-10-16$2.94/sh+5,000→ 5,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-10-16$13.76/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-09-15−53,000→ 127,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$2.94/sh+24,000→ 24,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$2.94/sh+24,000→ 24,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$16.87/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$2.94/sh+5,000→ 5,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$16.87/sh−24,000→ 0 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$16.87/sh−24,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-08-15−5,000→ 180,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-08-15$2.94/sh+5,000→ 5,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-08-15$11.91/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-07-14$2.94/sh+5,000→ 5,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-07-14−5,000→ 185,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-07-14$11.81/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-06-30−5,000→ 190,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-06-30$10.05/sh−5,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-06-30$2.94/sh+5,000→ 5,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-05-15−5,000→ 195,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-05-15$2.94/sh+5,000→ 5,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-05-15$10.37/sh−5,000→ 0 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-25+215,000→ 215,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-01-25+200,000→ 200,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2021-01-26+22,167→ 22,167 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2020-10-12+275,000→ 275,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-01-29+86,445→ 86,445 total

Companies

Recent Filings

Address

C/O ORUKA THERAPEUTICS, INC. 855 OAK GROVE AVE., SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov